Topic
cancer-treatment
42 stories related to this topic, newest first.
naturalnews.comscience2 days ago
Ivermectin prescriptions for cancer patients doubled from January to July 2025
A JAMA Network report found ivermectin prescriptions for cancer patients rose sharply after a January 2025 podcast appearance. Researchers linked the increase to celebrity comments on the Joe Rogan Experience. The study noted higher rates among white southern males.
Wiredscience2 days ago
London Clinic Uses Chlorine Dioxide Gas on Naked Patients
Alastair Jessel described administering Andreas Kalcker’s Protocol G at Battersea Park Clinic, sealing clients naked in plastic bags and exposing them to undiluted chlorine dioxide gas.
The Guardianscience7 days ago
Poolbeg Pharma to begin small trial of oral drug for preventing cytokine release syndrome in cancer patients at six NHS hospitals
The London startup will begin an intermediate trial of POLB 001 in 30 patients receiving Johnson & Johnson’s teclistamab. The study is led by the University of Manchester and the Christie NHS Foundation Trust.
forbes.comfinance10 days ago
Targeted Drug Extended Median Survival by About Six Months Versus Chemotherapy in Advanced Triple-Negative Breast Cancer Trial
More than 640 patients received either the antibody-drug conjugate or chemotherapy as first-line treatment. The targeted therapy extended median progression-free survival to nearly 11 months versus just under 6 months with chemotherapy.
science13 days ago
Australian pathologist Richard Scolyer dies at 59 after glioblastoma diagnosis
Richard Scolyer, a pathologist who advanced melanoma treatment, died Sunday at age 59. He had applied immunotherapy approaches first developed for melanoma to his own brain cancer.
thesouthafrican.comworld13 days ago
Nigerian Oncologist Completes First Radiotherapy PhD in South Africa
A doctor from Borno State completed a PhD comparing shorter and standard radiotherapy courses for breast, cervical, and prostate cancer at a Durban hospital. The research found comparable survival rates with reduced treatment time and cost.
Statscience17 days ago
Pancreatic Cancer Patient in Clinical Trial Plans to Seek Expanded Access to Daraxonrasib if Needed
Amy Johnston, 35, of Gilbertsville, Pa., plans to request daraxonrasib if her current trial fails. The drug nearly doubled survival time in earlier testing and is now available through an expanded access program.
winnipegfreepress.comscience17 days ago
Revolution Medicines pancreatic cancer drug advances toward second-line use
Daraxonrasib is positioned to become the standard second-line treatment for pancreatic cancer. Questions remain about its potential use in newly diagnosed patients.
news.sky.comscience18 days ago
NHS to offer new ovarian cancer drug to hundreds of patients
The National Institute for Health and Care Excellence approved mirvetuximab soravtansine for certain platinum-resistant ovarian cancers. NHS England estimates 400 patients in England could receive the treatment each year.
Fox Newsscience19 days ago
mRNA Therapy With Immunotherapy Cuts Melanoma Recurrence Risk by 49 Percent
A five-year follow-up of a phase 2b trial found the combination reduced recurrence or death compared with immunotherapy alone. The therapy is now in phase 3 testing for several cancers.
singularityhub.comworld21 days ago
Cancer Shot Eliminated Tumors in 15 of 102 Trial Participants
A clinical trial of an experimental cancer injection showed tumor shrinkage in 43 patients and complete tumor elimination in 15 others. The results come from a study involving 102 participants.
JE
newscientist.comscience21 days ago
Pancreatic Cancer Drug Shows Doubled Survival in Early Results
A medication called daraxonrasib produced more than double the survival time previously seen in pancreatic cancer patients. The drug also received FDA approval for an early access program and began shipping this week.
ER
The Timesscience21 days ago
Researchers Report Daily Pill Shows Promise in Cancer Treatment Studies
A research team announced results from trials of an oral medication designed to target cancer cells. The findings were presented as a potential advance for patients undergoing treatment.
freepressjournal.inscience23 days ago
Woman Travels to Turkey for Liver Transplant After NHS Denial
A 31-year-old woman with bile duct cancer was denied a liver transplant on the NHS and is seeking the procedure in Turkey. The couple launched a fundraiser to cover the £200,000 cost.
The Guardiantechnology29 days ago
UK startup launches drug crystallisation unit to International Space Station
BioOrbit sent a compact unit aboard a SpaceX rocket on 15 May to grow protein crystals in microgravity. The crystals are intended for use in self-injected cancer treatments after return to Earth.
Fox Newstechnology34 days ago
Alabama Teen Begins Experimental Cancer Treatment After Viral Video
A 15-year-old Alabama boy with stage 4 osteosarcoma started experimental gene therapy after a secretly posted Facebook video gained national attention. The video drew support from President Trump, Robert F. Kennedy Jr., and Dr. Mehmet Oz.
news.google.comworld35 days ago
Patient Describes Recovery One Year After CAR-T Therapy for Lymphoma
A Jerusalem Post opinion piece marks the one-year anniversary of a patient's CAR-T treatment for lymphoma. The author details physical changes and ongoing medical needs following the therapy.
JE
thebalitimes.comworld37 days ago
FDA Rejects Replimune Melanoma Treatment RP1
The Food and Drug Administration declined to approve RP1, a genetically engineered treatment for melanoma developed by Replimune. One-third of participants in a 140-patient clinical trial saw their tumors shrink or disappear. The agency cited the lack of a control arm comparing t…
medpagetoday.comscience38 days ago
NHS Approves Durvalumab for Treatment of Resectable Stomach Cancer
The National Institute for Health and Care Excellence has approved the immunotherapy drug durvalumab, also known as Imfinzi and made by AstraZeneca, for use by the NHS in adults with stomach cancer that has not spread extensively and can be surgically removed. An estimated 1,500…
forbes.comworld39 days ago
Startup Develops System To Track Cancer Treatment Response In Real Time
A startup valued at $250 million has created technology that monitors how tumors respond to cancer treatments as they occur. The system aims to provide physicians with immediate data on treatment effectiveness rather than waiting for traditional scans. Forbes reported the develop…
FO
New York Postworld39 days ago
Prescriptions for Ivermectin and Fenbendazole Rose Sharply Among Cancer Patients After Podcast Discussion
A study found prescriptions for ivermectin and fenbendazole among cancer patients increased more than 2.5 times in the months after actor-director Mel Gibson discussed the drugs on a January 2025 podcast episode. The combination saw the largest increases among young men, white pa…
gizmodo.comscience40 days ago
Cancer Patients Increased Use of Ivermectin After Mel Gibson Podcast Appearance
Prescriptions for ivermectin and fenbendazole rose sharply in the months after Mel Gibson told Joe Rogan that the drugs had cured Stage 4 cancer in three of his friends. A study published in JAMA Network Open found the rate of prescriptions among cancer patients more than doubled…
vancouversun.comworld42 days ago
Woman Survives Stage IV Breast Cancer Recurrence to Brain, Gives Birth to Second Child
Diagnosed with Stage II breast cancer at 29, Maralee Lellio later faced terminal Stage IV disease that spread to her brain. After aggressive treatment including a PARP inhibitor matched to her BRCA-1 positive cancer, she achieved two years cancer-free, paused medication and conce…
The Timesscience43 days ago
Ireland’s First Dedicated Private Skin Cancer Clinic to Open in South Dublin
A €4.7 million surgery centre in Ballsbridge will begin welcoming patients in July 2026 as skin cancer cases hit record levels. The clinic opens amid a government review that has recommended banning commercial sunbed use following a public consultation drawing nearly 9,500 respon…
medium.comworld43 days ago
Woman With Stage IV Breast Cancer Gives Birth After Brain Tumor Diagnosis
Maralee Lellio was diagnosed with Stage IV breast cancer that had spread to her brain in 2020. After undergoing treatment including radiation and a PARP inhibitor, she later became pregnant and gave birth to a second daughter in July 2024. She continues regular scans and is sched…
nypost.comworld45 days ago
Dave Coulier Reveals 45-Pound Weight Loss From Cancer Radiation Treatment
Dave Coulier, 66, said he lost 45 pounds after undergoing extensive radiation for throat cancer and chemotherapy for non-Hodgkin’s lymphoma. In an Instagram Reel posted Thursday, the Full House actor explained he has not eaten solid food in months and that the treatment affected…
The Independentworld45 days ago
NHS Cancer Nurses Exposed to Hazardous Drugs With Current PPE, Investigation Finds
A joint investigation by The Independent and Channel 4 News has found that NHS cancer nurses received only plastic aprons and gloves when handling hazardous drugs linked to miscarriage and infertility. The NHS West Midlands Cancer Alliance warned of risks including birth defects…
world45 days ago
Refugee in ICE Detention Missed Chemotherapy Sessions While Receiving Treatment for Terminal Cancer
A Laotian refugee who arrived in the United States in the early 1980s missed multiple chemotherapy sessions for terminal Hodgkin’s lymphoma while held in federal immigration detention. The 57-year-old man is now receiving hospice care after the cancer spread to his bone marrow. H…
fda.govworld46 days ago
FDA Grants Fast-Track Voucher to Partner Therapeutics for Bile Duct Cancer Therapy
The US FDA has awarded a new fast-track voucher to Partner Therapeutics for its bile duct cancer drug. The designation is intended to expedite regulatory review of the treatment. It marks the latest use of the agency's voucher program for therapies targeting rare or serious condi…
Nbc Newsscience46 days ago
Experimental Pancreatic Cancer Drug Doubles Survival in Advanced Cases
An experimental drug called daraxonrasib has shown it can double survival time for patients with advanced pancreatic cancer when combined with chemotherapy. The Food and Drug Administration has fast-tracked the drug for approval and allowed expanded access outside clinical trials…
nypost.compolitics47 days ago
15-Year-Old Alabama Boy Starts Experimental Cancer Treatment After Social Media Post Attracts Support
A 15-year-old boy from Alabama, battling stage four bone cancer for 16 months, began an experimental treatment in California after his plea reached the Trump administration. The administration connected him with the program in Santa Monica. He flew across the country and has star…
MA
The Timesscience48 days ago
NHS Rolls Out One-Minute Injection for Key Cancer Drug, Cutting Treatment Time
The UK's National Health Service is introducing an injectable form of the immunotherapy drug pembrolizumab, reducing administration time from up to two hours via intravenous drip to under a minute. This change affects treatment for 14 types of cancer and could benefit about 14,00…
ecns.cnpolitics58 days ago
Teddi Mellencamp Requested Weight Loss Medication During Stage 4 Cancer Treatment
Teddi Mellencamp discussed on her podcast that she asked doctors for GLP-1 weight loss medication to address steroid-induced weight gain during her Stage 4 cancer battle but was denied. She revealed she was cancer-free in October 2025 after a three-year fight that included multip…
France 24science67 days ago
Revolution Medicines' Daraxonrasib Trial Reports 13.2-Month Median Survival in Pancreatic Cancer Patients
Revolution Medicines announced results from a late-stage trial of its experimental oral drug daraxonrasib for pancreatic cancer patients. Patients receiving daraxonrasib had a median overall survival of 13.2 months, compared to 6.7 months for those on standard intravenous cytotox…
Substrate placeholder — needs reviewfinance69 days ago
Revolution Medicines' Daraxonrasib Succeeds in Phase 3 Trial for Pancreatic Cancer
Revolution Medicines announced that its targeted pill daraxonrasib met primary and secondary endpoints in a Phase 3 trial for metastatic pancreatic cancer patients. The drug extended median survival to 13.2 months compared to 6.7 months with chemotherapy and reduced the risk of d…
ST
Statscience69 days ago
Allogene Therapeutics Reports CAR-T Treatment Achieves Minimal Residual Disease Negativity in B-Cell Lymphoma Trial
Allogene Therapeutics announced interim results from a Phase 3 clinical trial of its off-the-shelf CAR-T therapy, cema-cel, for patients with B-cell lymphoma. The treatment achieved minimal residual disease negativity in 58% of patients, compared to 16% in the observation group.
Substrate placeholder — needs reviewworld70 days ago
GSK Plans Five Simultaneous Late-Stage Trials for Potential Blockbuster Cancer Drug
GSK Plc announced plans for five concurrent phase 3 trials of a targeted cancer therapy following promising early data. The initiative aims to advance the drug toward potential blockbuster status. The new CEO is leading efforts to revitalize the company's approach to innovation.
BU
RE
Substrate placeholder — needs reviewscience71 days ago
FDA Rejects Cancer Drug Candidate Lifileucel on Second Attempt After Prior Review
The U.S. Food and Drug Administration has rejected the cancer drug candidate lifileucel for the second time. The drug, developed by Iovance Biotherapeutics, targets advanced melanoma. This decision follows an earlier rejection in 2023 and involves issues with manufacturing and da…
ST
Substrate placeholder — needs reviewscience72 days ago
Challenges in Targeting Cancer Tumors with Immunotherapies and Viral Proteins
Immunotherapies and viral proteins that induce cell death serve as tools in cancer treatment. These methods face difficulties in selectively targeting tumors without affecting healthy cells. Researchers continue to explore ways to improve precision in such therapies.
NA
Substrate placeholder — needs reviewscience75 days ago
Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted Therapies
Many advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.
ST
Substrate placeholder — needs reviewscience75 days ago
Many Cancer Patients Not Receiving Genomic Testing Despite Treatment Advances
A report indicates that a significant number of cancer patients are not undergoing genomic testing, which can identify targeted therapies. This testing analyzes tumor DNA to match treatments to specific genetic mutations. The gap persists even as precision medicine options expand…
ST
Substrate placeholder — needs reviewscience77 days ago
Woman Describes Personal Transformation from Caregiving for Mother with Cancer
Amanda Cruz cared for her mother during a cancer diagnosis and treatment, an experience that altered her sense of self. Adult caregiving involves significant responsibilities, as highlighted in her account. The story illustrates the emotional and personal impacts of such roles on…